Bicycle Therapeutics plc (BCYC) Tops Q4 EPS by 8c

Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q4 EPS of ($1.16), $0.08 better than the analyst estimate of ($1.24). Revenue for the quarter came in at $5.33 million versus the consensus estimate of $6.62 million.

For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c
• Soligenix, Inc. (SNGX) Tops Q2 EPS by 8c